Table 1 Study demographics and baseline characteristics (n = 18)
Treatment group 1 (n = 6) | Treatment group 2 (n = 6) | Control group (n = 6) | Total (n = 18) | |
|---|---|---|---|---|
Age (years), mean (SD) | 26.3 (7.61) | 25.8 (11.11) | 28.2 (7.99) | 26.8 (8.55) |
Gender, n (%) | ||||
Male | 1 (16.7) | 2 (33.3) | 2 (33.3) | 5 (27.8) |
Female | 5 (83.3) | 4 (66.7) | 4 (66.7) | 13(72.2) |
Nationality, n (%) | ||||
Han | 5 (83.3) | 6 (100.0) | 6 (100.0) | 17 (94.4) |
Other | 1 (16.7) | 0 | 0 | 1 (5.6)) |
Height (m), mean (SD) | 1.6493 (0.0742) | 1.6547 (0.0399) | 1.6253(0.0717) | 1.6431 (0.0614) |
Weight (kg), mean (SD) | 59.42 (10.004) | 58.27 (7.464) | 57.78 (10.018) | 58.49 (8.708) |
Body surface area (m2), mean (SD) | 21.73 (2.328) | 21.23 (2.094) | 21.75 (2.469) | 21.57 (2.177) |
Neutrophil counts (×109/L), mean (SD) | 3.087 (0.7109) | 3.320 (1.0825) | 3.520 (0.8917) | 3.309 (0.8720) |